Oncology

A leading global international investment firm, Omega Funds has announced the closure of its sixth fundraising USD 438 Million. More than decade old Life Sciences-based investment firm specialized in direct secondary transactions, Omega funds focuses in investing in Life Sciences vertical, aiming to fulfil the unmet needs in the domain. Till date, the firm has successfully raised USD 1 Billion and has advanced the R&D in opting for an innovative treatment approach spanning across multiple therapeutic areas such as oncology, immunology, rare diseases, precision medicine and others. Known as ‘FUND VI’, the fund is a stage-agnostic and will have both earlier ...